Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
1849 E. 1450 Rd. , Lawrence, KS, 66044, US
CritiTech is a multi-service CDMO specializing in formulation development, particle engineering, drug development, analytical methods and testing, and preclinical to GMP manufacturing. We use spray drying and our proprietary Purcision platform to engineer non-cyto, cyto, potent, and inhaled drugs. CritiTech produces fast, impactful and quality results.
Released By Upperton
Launches hot melt extrusion platform at its Regensburg, Germany facility.
By: Charlie Sternberg
Strengthens Ofichem’s integrated development offering, enabling it to offer broader, deeper support from early-phase development through to GMP production.
Expands its capacity for assembly and packaging for the pharmaceutical sector.
New suite enables the scalable, diverse, high-quality conjugation services that customers need to advance to the next generation of therapies.
This investment expands Delpharm’s Saint-Rémy site.
By: Rachel Klemovitch
Establishes a Center of Excellence for Aseptic Fill-Finish Processing.
Why pharma needs automated AI security now.
By: Frank Balonis
Welcomes Brian Riley as President and Chief Technical Officer, Joanne Lager, MD as Chief Medical Officer, and Adrian Chaisson as Chief of Staff.
The U.S. launch of Conexxence and Bomyntra follows the FDA’s approval in March 2025.
Strengthens its global particle engineering capabilities.
Pharmaceutical service provider expands its footprint in the greater Chicago area.
Released By Vetter Pharma International
The company is investing $90 million to expand two U.S. facilities to enhance capacity and efficiency.
Villain offers extensive expertise in peptide and oligonucleotide development and manufacturing.
The companies have released the first batch of Novalgen’s next-generation T-cell engager for first in-human clinical trials.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
